迈普医学：国寿成达拟减持公司不超1%股份

Core Viewpoint - The announcement indicates that the pre-IPO shareholder, Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership), plans to reduce its stake in Maipu Medical through centralized bidding, which may impact the company's stock performance [1] Summary by Relevant Sections - Shareholder Reduction Plan - Guoshou Chengda intends to reduce its holdings by up to 670,500 shares, representing 1% of the company's total share capital [1] - This reduction accounts for 1.0036% of the total share capital after excluding shares held in the company's repurchase special account [1]